Science Board Meeting Could Launch US Toward Lawful Hemp Use, Or Extend Market Limbo
Executive Summary
Questions FDA is asking advisors and the public could generate answers propelling it toward determining whether hemp use in supplements should be lawful with a waiver of its prohibition against using ingredients studied or approved as a drug; or, the answers could stop the FDA in its feet.
You may also be interested in...
Cannabinoids Are Test Case For US FDA Advisors’ ‘Predicted Pharmacological Activity’ Discussion
Busy agenda of disparate topics in one-day meeting likely valuable for informing FDA on safety of hemp ingredients but not for moving toward a regulatory pathway for the ingredients' lawful use in supplements and food.
Plantwise Launches Supplement Line Focusing On 'Specialized Retailers'
Plantwise launched its CBD supplements in independent pharmacies in May with consultation consumers might not receive at larger chains.
Hemp Roundtable Says Safety Study Data Should Convince Congress On Lawful CBD Use
Study of 1,061 subjects showed oral CBD has robust safety profile, addressing FDA’s safety concerns and providing evidence to convince agency to take action on CBD regulation, say trade groups.